The objective of the Scheme is to generate credit risk-free returns through investments in sovereign securities issued by the Central Government and/or State Government(s) and/or any security uncondit...
Read MoreTo generate long term capital appreciation from a diversified portfolio of predominantly equity and equity related securities while offering deduction on such investment made in the scheme under secti...
Read MoreThe primary investment objective of the scheme is to generate long term growth of capital by predominantly investing in arbitrage opportunities present between the cash and derivate markets, as well a...
Read MoreThe investment objective of the scheme is to provide long-term capital appreciation from a portfolio investing in units of Mirae Asset Nifty India New Age Consumption ETF. The scheme does not guarante...
Read MoreThe investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty India New Age Consumption Total Return Index, subject to trackin...
Read MoreThe objective of the scheme is to invest in companies whose securities are included in Nifty 500 Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would...
Read MoreThe investment objective of the scheme is to generate returns that are in line with the performance of the BSE Capital Markets & Insurance Total Return Index, subject to tracking errors. There is no a...
Read MoreThe investment objective of the scheme is to generate returns corresponding to the total returns of the securities as represented by the CRISIL-IBX Financial Services 3 to 6 Months Debt Index before e...
Read MoreThe primary investment objective of the scheme is to generate long term growth by investing predominantly in a portfolio of equity and equity related instruments. However, there is no assurance or gua...
Read MoreThe objective of the scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies. However, there ...
Read More